Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
EXPRESS: NEUROPROTECTIVE EFFICACY OF AN OMEGA-3 DIGLYCERIDE EMULSION IN A PIGLET MODEL OF NEWBORN HYPOXIC-ISCHEMIC BRAIN DAMAGE.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Arruza Luis, Romero Angela, De Hoz Maria, Silva Laura, Martínez-Vega María, Rodríguez Maria José, Oikonomopoulou Niki, Vierge Eva, Aleo Esther, Ramos-Corral Raquel, Jurado-Parras Purificación, Zirpoli Hylde, Deckelbaum Richard, Martinez Orgado Jose Antonio
Аннотация
BACKGROUND: Acute injection of omega-3 fatty acids (n-3) formulated in a novel diglyceride (DG) lipid emulsion is neuroprotective after hypoxic-ischemic encephalopathy (HIE) in neonatal rodents.
METHODS: the efficacy of acute n-3 DG emulsion treatment was tested in 2-3-day-old piglets subjected to bilateral carotid artery clamping and 8% O₂ exposure for 30 min. Animals were randomly assigned to normothermia or hypothermia (HT, 34 ± 0.5 °C), then to n-3 DG or vehicle administration 30 min post-HI. Brain activity was assessed by amplitude-integrated EEG over 6 h. Brain injury was analyzed by TUNEL, GFAP and IBA-1 staining, ¹H-NMR spectroscopy (Lactate/NAA, Glutamate/NAA), and Western blot (caspase-3, TNF-α, IL-1β, protein carbonylation).
RESULTS: n-3 DG was well tolerated, with no hemodynamic or respiratory side effects. HT alone moderately improved brain activity and only reduced inflammation, whereas n-3 DG treatment partially restored early EEG recovery, attenuated cell death and neuroinflammatory markers, and limited protein carbonyl formation and GFAP+ cell loss. Notably, n-3 DG efficacy was preserved under HT conditions.
CONCLUSIONS: These results support the neuroprotective potential of n-3 DG emulsion in a piglet model of HIE, with promising implications for clinical translation.
METHODS: the efficacy of acute n-3 DG emulsion treatment was tested in 2-3-day-old piglets subjected to bilateral carotid artery clamping and 8% O₂ exposure for 30 min. Animals were randomly assigned to normothermia or hypothermia (HT, 34 ± 0.5 °C), then to n-3 DG or vehicle administration 30 min post-HI. Brain activity was assessed by amplitude-integrated EEG over 6 h. Brain injury was analyzed by TUNEL, GFAP and IBA-1 staining, ¹H-NMR spectroscopy (Lactate/NAA, Glutamate/NAA), and Western blot (caspase-3, TNF-α, IL-1β, protein carbonylation).
RESULTS: n-3 DG was well tolerated, with no hemodynamic or respiratory side effects. HT alone moderately improved brain activity and only reduced inflammation, whereas n-3 DG treatment partially restored early EEG recovery, attenuated cell death and neuroinflammatory markers, and limited protein carbonyl formation and GFAP+ cell loss. Notably, n-3 DG efficacy was preserved under HT conditions.
CONCLUSIONS: These results support the neuroprotective potential of n-3 DG emulsion in a piglet model of HIE, with promising implications for clinical translation.